🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary endpoint is to determine if ECP induces a decrease in % of tumo...
Status
Recruiting
Location
Emory University School of Medicine
Start Date
2023-04-04
Trial ID
NCT05157581
Treatments Being Tested
Hospitalization for elective knee or hip replacement surgery presents an ou...
Status
Completed
Location
New York University School of Medicine
Start Date
2019-01-15
Trial ID
NCT03673228
Hydroxycitrate (HCA) is a compound extracted from the fruit, Garcinia Cambo...
Status
Completed
Location
New York University School of Medicine
Start Date
2018-10-04
Trial ID
NCT03348228
Treatments Being Tested
This is a Phase II parallel group randomized controlled trial with 294 adol...
Status
Recruiting
Location
UConn Health
Start Date
2024-11-26
Trial ID
NCT06395467
This study hypothesizes that electroacupuncture combined with self-administ...
Status
Recruiting
Location
Qinghai University Affiliated Hospital
Start Date
2024-10-08
Trial ID
NCT06602167
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Status
Terminated
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Start Date
2013-03-15
Trial ID
NCT01732211
Treatments Being Tested
Study to determine the effect of multiple-dose BBT-877 on the single-dose p...
Status
Completed
Location
Celerion
Start Date
2019-09-17
Trial ID
NCT04138836
Treatments Being Tested
This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2025-08-10
Trial ID
NCT07106671
Treatments Being Tested